The latest price target for Motus GI Hldgs (OTCEM:MOTS) was reported by HC Wainwright & Co. on September 27, 2023. The analyst firm set a price target for $2.50 expecting MOTS to rise to within 12 ...

Tim Moran transitions from Chief Executive Officer to Chairman of the Board and Mark Pomeranz appointed Chief Executive Officer to lead next phase of Company Restructuring plan reduces operating ...

Medical technology company Motus GI is offering $20 million in common stock priced at $3 a share to the public to fund commercialization of its Pure-Vu system for colonoscopies. 1. The offering, which ...

FORT LAUDERDALE, Fla., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and ...

Endoscopy solutions company Motus GI has been named the sole source provider for the Veterans Health Administration, the largest integrated health system in the U.S. for over nine million veterans.

Prep-less colonoscopy solutions developer Motus GI Medical Technologies has secured $8 million from U.S. life sciences venture capital funds. Prep-less colonoscopy solutions developer Motus GI Medical ...

Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit ...

The upper GI procedure was performed by Dr. Brian Hanson, gastroenterologist and Assistant Professor, Medicine, at the University of Minnesota Pure-Vu EVS Gastro addresses the Upper GI market, an area ...